April 25, 2024 17:33 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Lok Sabha Elections 2024: ECI issues notices to BJP, Congress on complaints against Modi, Rahul | Massive landslide hits Arunachal Pradesh, a large section of Highway-33 washed away | Actress Tamannaah Bhatia summoned by Maharashtra cyber cell in 2023 illegal IPL streaming case | Bihar CM Nitish Kumar's party leader shot dead in Patna | Centre moves Supreme Court seeking modification of 2012 verdict in 2G spectrum case
Strides Pharma Q4FY23 sales at Rs 9,904 million cr, up 14%Y-o-Y; loss narrows 133% YoY to Rs 9.54 cr

Strides Pharma Q4FY23 sales at Rs 9,904 million cr, up 14%Y-o-Y; loss narrows 133% YoY to Rs 9.54 cr

Mumbai: Strides Pharma’s quarterly sales stood at Rs 9,904 million, growing 14% increase both sequentially and year-on-year.

Strides Pharma records 11 pc YoY revenue increase in Q2FY21

Strides Pharma records 11 pc YoY revenue increase in Q2FY21

Kolkata/IBNS: Strides Pharma Science Ltd (BSE: 532531, NSE: STAR) today announced its consolidated financial results for the quarter (Q2FY21).